This page shows the latest Bluebird Bio news and features for those working in and with pharma, biotech and healthcare.
Celgene boosts CAR-T stake again with Bluebird Bio deal. The US biotech could receive $70m in development milestones for the candidate. ... Mere weeks after completing its acquisition of CAR-T specialist Juno, Celgene has added to its cell therapy
rival to Bluebird Bio’s BB2121, which Celgene licenses.
from Bluebird Bio were highlighted.
There was also good news from another earlier trial of a BCMA-targeting CAR-T bb2121 being developed by Celgene and Bluebird Bio, which showed the candidate was able to achieve
Other CAR-T players, like Juno and Bluebird Bio, are a little further back in development.
Meanwhile, down the line patients could see potential gene therapy treatments start to appear from the likes of Biogen/Sangamo and Bluebird Bio.
More from news
Approximately 2 fully matching, plus 11 partially matching documents found.
The lead programme EM801 is a T cell bispecific antibody targeting B-cell maturation antigen (BCMA), which s considered to be complementary to Bluebird bio's CAR T cell therapies targeting ... 1, 695. Medigene /Bluebird bio. Licence. Development and
Interestingly though, it is not always the major players as evidenced by the deals between bluebird bio with Five Prime Therapeutics and Editas with Juno Therapeutics. ... Five Prime/ bluebird bio. Licence agreement. For development of CAR-T cell
208. Pregenen/ bluebird bio. Company acquisition. Gene editing technology platform. 156.
344. Bluebird bio/ Celgene Corporation. Option &licence. CAR T-cell therapy for oncology (platform).
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Celgene boosts CAR-T stake again with Bluebird Bio deal. The US biotech could receive $70m in development milestones for the candidate. ... Mere weeks after completing its acquisition of CAR-T specialist Juno, Celgene has added to its cell therapy
James DeTore (pictured) becomes the biopharmaceutical firm's chief financial officer, bringing experience from bluebird bio, Ironwood Pharmaceuticals and Microbia.
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....